Earnings AlertsSmartkarma Newswire

China Overseas Land & Investment Earnings Soar 29.35B Yuan – +11% Y/Y YTD – 34 Buys, 1 Hold, 0 Sells


  • China Overseas Land reported contracted sales of 29.35 billion yuan, a 11% increase from the same time last year.
  • Year-to-date, contracted sales have totaled 146.98 billion yuan, a 55% increase from the same period last year.
  • 34 analysts rate China Overseas Land a buy, 1 rate it a hold, and 0 rate it a sell.

China Overseas Land & Investment on Smartkarma

Recent analyst coverage of China Overseas Land & Investment (688 HK) has been mainly positive. Jacob Cheng of Smartkarma recommends buying the stock as long as it trades below HKD20, citing its attractive valuation and potential for growth. David Coloretti of TMA has also weighed in, noting a large triple bottom in 2021/2022 that has confirmed a likely multi-year base and evolving uptrend, with a bullish weekly reversal pattern last week confirming that the 2023 correction is likely complete.

Cheng and Coloretti both believe that China Overseas Land & Investment offers investors a safe play with potential for upside. Cheng highlights the company’s lack of liquidity and bankruptcy risk, while Coloretti focuses on the momentum confirmation that suggests a target of 23.20 (+11%) and 27.35 (+30%) if the stock breaks above the initial target.


A look at China Overseas Land & Investment Smart Scores

China Overseas Land & Investment Limited is a global real estate services provider. According to Smartkarma Smart Scores, the company has an overall outlook of good with a score of 4 for value and dividends, 3 for growth, 2 for resilience, and 3 for momentum.

The company has been steadily increasing its investments in commercial properties and is well-positioned to capitalize on future opportunities. As the company expands its presence in the global real estate market, it is expected to continue to be a reliable provider of real estate services.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Data and News
  • βœ“ Events & Webinars